Skip to main content
NeuronFeed

Gestalt Diagnostics · Series A

AI-enabled digital pathology platform for cancer diagnosis

Amount

$7.5M

Round

Series A

Valuation

Announced

Apr 2025

Investors

Lead investor

Cowles Ventures

Participating investors

📎 Source